SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-073079
Filing Date
2023-12-26
Accepted
2023-12-26 17:00:41
Documents
13
Period of Report
2023-12-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K meip-20231219.htm   iXBRL 8-K 43934
2 EX-16.1 meip-ex16_1.htm EX-16.1 4364
  Complete submission text file 0000950170-23-073079.txt   163764

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20231219.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20231219_pre.xml EX-101.PRE 9455
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20231219_lab.xml EX-101.LAB 12798
7 EXTRACTED XBRL INSTANCE DOCUMENT meip-20231219_htm.xml XML 4524
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41827 | Film No.: 231513887
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)